![180 Life Sciences](https://gocience.com/logos/new/b162368419b71d801c263d8af219e46dec831c120262f9b20009c00af2c80214.png)
180 Life Sciences
Biotechnology, 150 W 56th St, New York, 10019, United States, 1-10 Employees
Who is 180 LIFE SCIENCES
180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and ...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: 150 W 56th St, New York, New York, 10019, United States
-
Employees: 1-10
-
Revenue: $5 Million to $10 Million
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from 180 LIFE SCIENCES
180 Life Sciences Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding 180 Life Sciences
Answer: 180 Life Sciences's headquarters are located at 150 W 56th St, New York, 10019, United States
Answer: 180 Life Sciences's official website is https://180lifesciences.com
Answer: 180 Life Sciences's revenue is $5 Million to $10 Million
Answer: 180 Life Sciences's SIC: 2834
Answer: 180 Life Sciences has 1-10 employees
Answer: 180 Life Sciences is in Biotechnology
Answer: 180 Life Sciences contact info: Phone number: Website: https://180lifesciences.com
Answer: 180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the worlds biggest drivers of disease inflammation. The Company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Companys primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor).
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month